Patent directory · USPTO A61K / A61P
Patents matching “THE UNITED STATES OF AMERICA AS REPRESENTED BY THE”
783 pharma patents match "THE UNITED STATES OF AMERICA AS REPRESENTED BY THE" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 783 pharmaceutical patents matching "THE UNITED STATES OF AMERICA AS REPRESENTED BY THE" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 9758761
Aligned and electrospun piezoelectric polymer fiber assembly and scaffold
granted -
US 9724376
Olive leaf powder
granted -
US 9700578
Use of nitrite salts for the treatment of cardiovascular conditions
granted -
US 9687542
Rift valley fever virus replicon particles and use thereof
granted -
US 9683024
Recombinantly expressed plasmodium CelTOS antigen and methods of use thereof
granted -
US 9682107
Postnatal stem cells and uses thereof
granted -
US 9682088
Method for treating uterine fibroids
granted -
US 9675572
Intravenous omega-3 fatty acid compositions and method of use
granted -
US 9676858
Human bispecific EGFRvIII antibody and CD3 engaging molecules
granted -
US 9675684
Gene optimized hantaan virus M segment DNA vaccine for hemorrhagic fever with renal syndrome
granted -
US 9675637
Use of nitrite salts for the treatment of cardiovascular conditions
granted -
US 9650422
Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes and methods for their use
granted -
US 9651462
Method and system for sampling and separating submicron-sized particles based on density and/or size to detect the presence of a particular agent
granted -
US 9629816
Small molecule therapeutic compounds targeting thioesterase deficiency disorders and methods of using the same
granted -
US 9623097
Yeast-brachyury immunotherapeutic compositions
granted -
US 9617526
Mutated organophosphorus acid anhydrolases and their uses thereof
granted -
US 9598492
Human monoclonal antibodies specific for CD22
granted -
US 9598441
Therapeutic compounds and methods
granted -
US 9592304
Recombinant antibodies and immunoconjugates targeted to CD-22 bearing cells and tumors
granted -
US 9587232
Mutated organophosphorus acid anhydrolases and their uses thereof
granted -
US 9567566
HMGN polypeptides as immune enhancers and HMGN antagonists as immune suppressants
granted -
US 9555064
Protease-deficient Bacillus anthracis
granted -
US 9546151
VMAT inhibitory compounds
granted -
US 9533031
Yeast-MUC1 immunotherapeutic compositions and uses thereof
granted